Stockscreener 앱 받기
135.16
1.57%
1.74
Glaukos Corp 주식(GKOS)의 최신 뉴스
Glaukos president & COO Gilliam sells $2.8m in company stock By Investing.com - Investing.com South Africa
Glaukos SVP & CFO Alex Thurman sells $1.4m in shares - Investing.com
Glaukos president & COO Gilliam sells $2.8m in company stock - Investing.com India
Glaukos (GKOS) CFO exercises options and sells 10,000 shares under plan - Stock Titan
GLAUKOS (GKOS) President & COO sells 19,573 shares in open-market trade - Stock Titan
GLAUKOS (GKOS) director Leana Wen sells 1,700 shares, holds 19,739 - Stock Titan
Glaukos Corp Leads Innovation in Chronic Eye Disease Treatment with iDose TR and Epioxa Therapies – 2026 Investor Update - Minichart
[8-K] GLAUKOS Corp Reports Material Event - Stock Titan
Glaukos wins permanent J-code for Epioxa keratoconus therapy - MSN
How The Glaukos (GKOS) Narrative Is Shifting With New Guidance And Product Ramp Expectations - Yahoo Finance
UBS Group AG Increases Position in Glaukos Corporation $GKOS - MarketBeat
MSN Money - MSN
Earnings Update: Here's Why Analysts Just Lifted Their Glaukos Corporation (NYSE:GKOS) Price Target To US$148 - Sahm
Glaukos (NYSE:GKOS) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Glaukos Corp. Earnings Call Signals Growth Momentum - The Globe and Mail
[144] GLAUKOS Corp SEC Filing - Stock Titan
Glaukos Up Over 19%, On Track for Largest Percent Increase Since December 2023 -- Data Talk - Moomoo
Fidelity Brokerage Services LLC (GKOS) files Form 144 to sell 19,573 shares - Stock Titan
Glaukos (GKOS) Q1 Loss Of US$0.34 EPS Reinforces Bearish Profitability Narrative - Sahm
GKOS SWOT Analysis: Key Insights from the 10-Q Filing - GuruFocus
GKOS Maintains Overweight Rating by JP Morgan -- Price Target Ra - GuruFocus
GKOS Maintained by Citigroup -- Price Target Raised to $140 - GuruFocus
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) Stock - MarketBeat
Glaukos (GKOS) Jumps As Earnings Beat Fuels Bullish Outlook - StocksToTrade
Glaukos stock reaches 52-week high at $143.81 By Investing.com - Investing.com Canada
GKOS Maintained by Wells Fargo -- Price Target Raised to $138.00 - GuruFocus
Midday Stock Roundup: Alignment Healthcare Shares Fall 12% Following Q1 Earnings - Orange County Business Journal
Glaukos Gains on Q1 Earnings Beat & Improved 2026 Revenue Outlook - Zacks Investment Research
Glaukos Stock Surges 18% on Record Q1 Sales Beat and Raised 2026 Outlook as iDose TR Demand Soars - International Business Times Australia
GKOS Maintained by BTIG -- Price Target Raised to $141.00 - GuruFocus
GKOS Maintained by Needham -- Price Target Raised to $136 - GuruFocus
Glaukos (GKOS) Rule 144: Fidelity lists 10,000‑share resale, insider trades - Stock Titan
Glaukos (NYSE:GKOS) Sets New 1-Year High After Earnings Beat - MarketBeat
Wells Fargo & Company Raises Glaukos (NYSE:GKOS) Price Target to $138.00 - MarketBeat
Glaukos stock reaches 52-week high at $143.81 - Investing.com UK
Glaukos Corporation (NYSE:GKOS) Q1 2026 Earnings Call Transcript - Insider Monkey
Glaukos (NYSE:GKOS) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Needham & Company LLC Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) Stock - MarketBeat
Needham raises Glaukos stock price target to $136 on revenue beat By Investing.com - Investing.com South Africa
Needham raises Glaukos stock price target to $136 on revenue beat - Investing.com
BTIG raises Glaukos stock price target to $141 on strong results - Investing.com
BTIG raises Glaukos stock price target to $141 on strong results By Investing.com - Investing.com South Africa
Glaukos Q1 Earnings Call Highlights - MarketBeat
Glaukos Corp (GKOS) Q1 2026 Earnings Call Highlights: Record Sal - GuruFocus
Glaukos Announces First Quarter 2026 Financial Results - BioSpace
Glaukos 1Q Loss $19.8M >GKOS - Moomoo
Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Glaukos Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Glaukos (GKOS) Reports Strong Q1 Revenue Growth - GuruFocus
Glaukos (GKOS) Q1 2026 Earnings Transcript - The Globe and Mail
Earnings call transcript: Glaukos Corp beats Q1 2026 forecasts, stock dips By Investing.com - Investing.com Australia
Glaukos (GKOS) Forecasts FY26 Revenue Between $620M and $635M - GuruFocus
Is Glaukos (GKOS) Still 6.0% Undervalued After Q1 Earnings Beat? - GuruFocus
Glaukos (NYSE:GKOS) Posts Earnings Results, Beats Expectations By $0.12 EPS - MarketBeat
Glaukos (GKOS) posts 41% Q1 revenue growth but remains unprofitable - Stock Titan
0.76%
0.72%
자본화:
|
볼륨(24시간):